Download PDF Register Interest

Global pipeline

Women’s Health

Ospemifene
Post-menopausal vaginal atrophy
+
Phase 1


+
Phase 3

+
Regulatory approval
USA: Approval (Feb. 2013)

Europe: Approval (Jan. 2015)